Instytut Matki I Dziecka — Clinical Trial Site

18 Registered trials

11 Currently recruiting

Organisation

Instytut Matki I Dziecka

Location

Warsaw, Poland

Identifier

ORG-100031311

Address

Ul Marcina Kasprzaka 17 A, 01-211, Poland

Departments

"Department of Oncology and Surgical Oncology for Children and Youth"
Children Neurology Clinic
Department of Oncology and Oncological Surgery for Children and Adolescents
Dept. of Oncology and Surgical Oncology f. children and Youth
Dept. of Oncology and Surgical Oncology for Children and Youth
Inborn Errors of Metabolism and Pediatrics
Klinika Neurologii Dzieci i Młodzieży
Klinika Onkologii i Chirurgii Onkologicznej Dzieci i Młodzieży
Klinika Poloznictwa i Ginekologii
Klinika Położnictwa i Ginekologii
Klinika Wrodzonych Wad Metabolizmu i Pediatrii

Clinical trials at this site (18)

Search interface

Clinical trial (study) comparing the efficacy and safety of mifamurtide versus standard treatment containing sorafenib in pediatric and youn… Pending

2026-525223-24-00 Relapsed/refractory osteosarcoma, High-grade osteosarco 4
Efficacy and Safety Study of Once-Daily Extended-Release Levetiracetam in Drug-resistant Focal Onset Seizures Recruiting

2024-514499-42-00 Refractory Partial Onset Epilepsy 5 2025-03-12
Multicenter, Open-Label, Randomized Study of Nipocalimab or IVIG in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (F… Recruiting

2023-509434-19-00 Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT) 5 2025-02-10
A study of sepiapterin in participants with phenylketonuria (PKU) (EPIPHENY) Recruiting

2024-514435-20-00 Phenylketonuria 5 2025-12-23
An open-label, pharmacokinetic, safety, and efficacy study (Part I, single cycle) and double-blind, efficacy, non inferiority, and safety st… Recruiting

2024-514321-39-00 Chemotherapy-induced nausea and vomiting 10 2025-05-06
Clinical trial (study) comparing the efficacy and safety of valacyclovir used in the prevention and treatment of primary cytomegalovirus (CM… Recruiting

2023-508643-46-00 primary cytomegalovirus (CMV) infection 4 2024-08-02
A Phase 3 Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN) Recruiting

2022-502629-16-00 Hemolytic Disease of the Fetus and Newborn (HDFN) 5 2024-07-10
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma. Recruiting

2024-514441-11-00 Ewing's sarcoma 4 2023-09-28
A 20-Week Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of EPX-100 (Clemizole Hydrochloride) as Adjunctive Therapy in Chil… Recruiting

2024-518628-57-00 Dravet syndrome 5 2023-08-01
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma Recruiting

2022-501180-40-00 Ewing Sarcoma 5 2022-06-17
To check the safety, efficacy and tolerability of the drug vemurafenib, and to determine the duration of treatment in children with BRAF mut… Recruiting

2024-515805-25-00 histiocytic cell proliferation 4 2021-05-13
Examination of the molecular profile in adolescent patients with histiocytic cell hyperplasia, and if a specific mutation is detected, its m… Recruiting

2024-515895-11-00 histiocytic cell proliferation 6 2021-04-15
A Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 in Participants with PMM2-CDG Ended

2024-520109-37-00 PMM2-CDG 4 2025-07-09
LCH-IV International Collaborative Treatment Protocol for Children and Adolescents with Langerhans Cell Histiocytosis Ended

2024-512676-36-00 Langerhans Cell Histiocytosis 10 2024-10-09
A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria Ended

2023-509229-31-00 Metabolic Disorders - Phenylketonuria 5 2022-09-28
To evaluate the efficacy and safety of regorafenib in patients with refractory primary bone tumors. Ended

2024-514720-17-00 Refractory primary bone tumors 4 2022-04-29
To test the safety, efficacy and tolerability of a drug called trametinib and determine the duration of treatment in children with histiocyt… Ended

2024-515896-37-00 histiocytic cell proliferation 4 2021-04-20
A Phase 3, Randomized, Crossover, Open-Label, Active-Controlled Study of Sepiapterin versus Sapropterin in Participants With Phenylketonuria… Ended

2023-506238-61-00 Phenylketonuria 5 2024-05-10